Association between Fluorescent Advanced Glycation End-Products and Vascular Complications in Type 2 Diabetic Patients

Figure 2

Box-plot distribution of biomarker values in the diabetic group with and without vascular disease groups (resp., VD and NVD). (a) Thiol levels (μmol/g protein); (b) IMA index (AU/g albumin); (c) Glycated albumin levels (mg/mL); (d) Fructosamine levels (mol/g protein); (e) Fluo-AGE levels (AU/g); (f) AGE levels (μg/mL). The horizontal bars in the box represent the median; the box boundaries represent the 25th and 75th percentile values. indicates a significant difference versus NVD group.

(a)

(b)

(c)

(d)

(e)

(f)